Stanford Pediatric Healthy Weight Index for Obesity & Overweight
This study is developing a simple way to measure how well the body uses insulin and overall heart and metabolic health in children and teenagers with obesity. It uses a Remote Monitoring Program where participants wear continuous glucose monitors and fitness trackers. Researchers will collect data from these devices, along with lab tests, to understand how activity and glucose levels relate to metabolic problems. You may be able to join if you are 10 to 18 years old, have Class 2 or 3 obesity, and are already in the Adolescent Bariatric Program at Stanford Children's, eligible for either bariatric surgery or GLP1 Receptor Agonist Therapy. The study aims to see how much body mass index (BMI), body weight, and fasting glucose levels change over about 4 months. The current recruitment status is unclear.
- Study design
- This is an interventional study with a planned enrollment of 120 participants. It is a prospective cohort study, meaning participants are followed over time.
- What's involved
- You would wear a continuous glucose monitor and a wearable fitness device for the duration of the study. Monitoring will occur at three time points: before treatment, during early treatment, and 3 months after treatment or dose stabilization.
- Compensation
- Not stated in the trial record.
- Follow-up
- Primary endpoints are measured from baseline through study completion, which is an average of 4 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Stanford Pediatric Healthy Weight Index
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Percent Reduction in BMIbaseline through study completion, an average of 4 months
assessment of change in BMI from pre-intervention to post-intervention
- Body Weightbaseline through study completion, an average of 4 months
Change in body weight (kg)
- Fasting Glucosebaseline through study completion, an average of 4 months
change in fasting glucose levels from pre-intervention to post-intervention
- Fasting Insulinbaseline through study completion, an average of 4 months
change in fasting insulin levels from pre-intervention to post-intervention
- HbA1cbaseline through study completion, an average of 4 months
change in HbA1c levels from pre-intervention to post-intervention
- Lipid Panelbaseline through study completion, an average of 4 months
changes in lipid panel levels from pre-intervention to post-intervention
- Liver Enzymesbaseline through study completion, an average of 4 months
changes in liver enzymes from pre-intervention to post-intervention